Find out all about your favorite commercial!

Advertisers

Advertisers of the Prevnar 13 TV Spot, 'Prevención'

Prevnar 13 TV commercial - Prevención
Prevnar 13

Prevnar 13 is a pneumococcal conjugate vaccine developed by the company Pfizer. It is designed to protect against infections caused by 13 different strains of Streptococcus pneumoniae, a bacterium res...

What the Prevnar 13 TV commercial - Prevención is about.

Prevnar 13 TV commercial - Prevención

In the vibrant world of advertising, where storytelling takes center stage, the Prevnar 13 TV Spot titled 'Prevención' emerges as a captivating and informative piece. This 30-second commercial effortlessly weaves together visuals, emotions, and messaging to highlight the importance of prevention through vaccination.

As the spot begins, we are introduced to a bustling urban setting, filled with diverse individuals going about their daily lives. The camera pans across the cityscape, emphasizing the vibrancy and interconnectedness of the community. The background track subtly sets the tone, blending soft melodies with a sense of urgency.

Amidst the urban landscape, we catch glimpses of parents engaging with their children - a tender moment of nurturing and protection. A mother tenderly holds her newborn baby, a father playfully lifts his child high in the air. These heartwarming scenes evoke an instant connection with the audience, tapping into the universal experience of parental love and care.

Simultaneously, informative text overlays appear, concisely communicating the importance of vaccination as a fundamental prevention method in safeguarding the health of children. The text emphasizes the power of Prevnar 13, a trusted pneumococcal vaccine endorsed by medical professionals worldwide.

The visuals transition seamlessly into a sequence highlighting the active, joyful lives of children. We witness kids engaging in a wide array of activities - playing soccer, laughing at a birthday party, exploring nature. These energetic scenes underscore the significance of vaccination in allowing children to lead healthy, uninhibited lives.

Importantly, 'Prevención' goes beyond surface-level storytelling. It emphasizes the importance of community responsibility in safeguarding children's health. The camera pans across a diverse group of adults, including parents, grandparents, and healthcare professionals, all supporting each other in the endeavor to protect the youngest members of society.

As the commercial nears its conclusion, uplifting music swells, and the screen fills with the words, "Prevención empieza con protección" (Prevention begins with protection). This tagline encapsulates the essence of the spot, emphasizing the pivotal role that vaccination plays in safeguarding communities and building a healthier future for generations to come.

In its brief yet impactful runtime, 'Prevención' succeeds in delivering a powerful message about the importance of vaccination, specifically Prevnar 13. Through its visually captivating storytelling, the TV spot effectively engages the audience, evokes emotions, and educates viewers about the vital role of prevention in children's health. It serves as a reminder that by taking proactive measures, we can create a safer

Prevnar 13 TV commercial - Prevención produced for Prevnar 13 was first shown on television on September 11, 2018.

Frequently Asked Questions about prevnar 13 tv spot, 'prevención'

This vaccine is used to help protect from infection due to a certain bacteria (Streptococcus pneumoniae). This bacteria can cause ear infection or other more serious infections (such as pneumonia, meningitis). Some brands are approved for use only in children, while others can be used in both children and adults.

The US Food and Drug Administration (FDA) approved Pfizer's pneumococcal conjugate vaccine Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) as a single dose for use in adults on December 31, 2011.

The pneumococcal vaccine prevents pneumococcus bacterial infections. These bacteria can cause infections like pneumonia and meningitis. This vaccine won't treat an infection and won't cause an infection.

Prevenar 13 contains the polysaccharides from 13 different types of S. pneumoniae (serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F).

One pneumonia vaccine (Prevnar 13) has an unknown immunity duration, while the other (Pneumovax 23) lasts from five to 10 years. Pneumonia is an infection of the lungs that causes cough, fever, and trouble breathing.

CDC recommends the use of PCV13 for the routine vaccination of children younger than 5 years of age (4-dose series at age 2 months, 4 months, 6 months, and 12–15 months) and children 6 years and older without prior PCV13 vaccination who have certain medical conditions that put them at high risk of invasive pneumococcal ...

The first pneumococcal conjugate vaccine (Prevnar 7, PCV7) was licensed for use in the United States in 2000. It included purified capsular polysaccharide of seven serotypes of S. pneumoniae. In 2010, a 13-valent pneumococcal conjugate vaccine (PCV13, Prevnar 13) was licensed in the United States.

About Prevnar 13 Prevnar 13 was first introduced for use in infants and young children in December 2009 in Europe and in February 2010 in the U.S., and it is now approved for such use in nearly 120 countries worldwide.

One pneumonia vaccine (Prevnar 13) has an unknown immunity duration, while the other (Pneumovax 23) lasts from five to 10 years. Pneumonia is an infection of the lungs that causes cough, fever, and trouble breathing.

One pneumonia vaccine (Prevnar 13) has an unknown immunity duration, while the other (Pneumovax 23) lasts from five to 10 years. Pneumonia is an infection of the lungs that causes cough, fever, and trouble breathing.

Received PCV13 at Any Age and PPSV3 Before Age 65 Years Give 1 dose of PCV20 or PPSV23. Regardless of vaccine used, their series is complete. The PCV20 dose should be given at least 5 years after the last pneumococcal vaccine. The PPSV23 dose should be given at least 5 years after the last PPSV23 dose.

Administer 1 dose of PCV13 at 65 years or older. This dose should be given at least 1 year after PPSV23. Administer 1 final dose of PPSV23 at 65 years or older. This dose should be given at least 1 year after PCV13 and at least 5 years after the most recent dose of PPSV23.

Videos

Watch Prevnar 13 TV Commercial, 'Prevención'

We analyzed TV commercials placed on popular platforms and found the most relevant videos for you:

Agenices

Agenices of the Prevnar 13 TV Spot, 'Prevención'

Prevnar 13 TV commercial - Prevención
RTC Relationship Marketing

RTC Relationship Marketing is a leading marketing firm that specializes in building and maintaining relationships with customers. The company focuses on creating personalized experiences for clients t...

Products

Products Advertised

Prevnar 13
TV commercials

Similar commercials

Prevnar 13 TV Spot, 'Prevention'
324 August 29, 2018
Trulicity TV Spot, 'My Sister'
1168 April 13, 2022
Flonase Sensimist TV Spot, 'National Geographic: Einstein'
Prevnar 13 TV Spot, 'Alto riesgo'
515 October 8, 2017
Prevnar 13 TV Spot, 'Don't Miss Out on Life'
Trulicity TV Spot, 'Daughter: A1C'
886 October 11, 2021
Vonage Nationwide Calling TV Spot, '39%'
Xfinity Voice TV Spot, 'Save Big'
382 November 3, 2013
Express Jeans TV Spot, 'Fit for You: Labor Day' Song by Saint Motel
Express TV Spot, 'Design Your Future. Work Your Style.'
FOCUSFactor TV Spot, 'Get Your Einstein On'
State Farm TV Spot, 'Wrong/Right'